Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme: Inhibition of coreceptor function

Shrabani Basu, Bandi Sriram, Ritu Goila, Akhil C. Banerjea

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

HIV needs the chemokine receptors (HIV-1 coreceptors) to initiate infection and gain entry into a susceptible cell. CCR5 receptor is used by macrophage tropic viruses to establish infection, and CXCR-4 is used by T lymphocyte tropic virus which are usually found at the terminal stages of the disease. These chemokine receptors are, therefore, attractive targets to interfere with the entry as well as spread of HIV-1 in the host. As our antiviral approach, we have earlier assembled a DNA-enzyme-916 against CCR5 (Goila and Banerjea, 1998). We have now designed against the CXCR-4 gene a mono-DNA-enzyme, which showed sequence specific cleavage activity. When CXCR- 4-DNA-enzyme was placed in tandem with CCR5-DNA-enzyme, specific cleavage of their respective target sites were observed using a 60 bases long synthetic target RNA which possessed the target sites for both the DNA-enzymes. The cleavage by the CXCR-4 DNA-enzyme was found to be significantly more efficient than by the CCR5-DNA-enzyme. Analyses of the cleaved fragments by mono- and di-DNA-enzyme indicated strongly that hybridization of the CCR5- DNA-enzyme with its cognate target RNA, actually facilitated the cleavage by the CXCR-4 DNA-enzyme. Furthermore, the di-DNA-enzyme was able to cleave the substrate RNA to completion. These DNA-enzymes, when introduced into a mammalian cell line expressing the appropriate chemokine receptor, interfered specifically with the HIV-1 coreceptor functions. Using this strategy, it may be possible to interfere with the infection and spread of R5 as well as X4 viruses. (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)125-134
Number of pages10
JournalAntiviral Research
Volume46
Issue number2
DOIs
StatePublished - May 2000
Externally publishedYes

Fingerprint

HIV-1
RNA
DNA
Enzymes
Chemokine Receptors
Viruses
Infection
CCR5 Receptors
Antiviral Agents
Macrophages
HIV
T-Lymphocytes
Cell Line

Keywords

  • Catalytic DNA
  • CCR5
  • Chemokine receptors
  • CXCR-4
  • DNA-enzymes
  • HIV-1 coreceptors

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme : Inhibition of coreceptor function. / Basu, Shrabani; Sriram, Bandi; Goila, Ritu; Banerjea, Akhil C.

In: Antiviral Research, Vol. 46, No. 2, 05.2000, p. 125-134.

Research output: Contribution to journalArticle

Basu, Shrabani ; Sriram, Bandi ; Goila, Ritu ; Banerjea, Akhil C. / Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme : Inhibition of coreceptor function. In: Antiviral Research. 2000 ; Vol. 46, No. 2. pp. 125-134.
@article{c0a3333375e24d66b10fc64fcda96099,
title = "Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme: Inhibition of coreceptor function",
abstract = "HIV needs the chemokine receptors (HIV-1 coreceptors) to initiate infection and gain entry into a susceptible cell. CCR5 receptor is used by macrophage tropic viruses to establish infection, and CXCR-4 is used by T lymphocyte tropic virus which are usually found at the terminal stages of the disease. These chemokine receptors are, therefore, attractive targets to interfere with the entry as well as spread of HIV-1 in the host. As our antiviral approach, we have earlier assembled a DNA-enzyme-916 against CCR5 (Goila and Banerjea, 1998). We have now designed against the CXCR-4 gene a mono-DNA-enzyme, which showed sequence specific cleavage activity. When CXCR- 4-DNA-enzyme was placed in tandem with CCR5-DNA-enzyme, specific cleavage of their respective target sites were observed using a 60 bases long synthetic target RNA which possessed the target sites for both the DNA-enzymes. The cleavage by the CXCR-4 DNA-enzyme was found to be significantly more efficient than by the CCR5-DNA-enzyme. Analyses of the cleaved fragments by mono- and di-DNA-enzyme indicated strongly that hybridization of the CCR5- DNA-enzyme with its cognate target RNA, actually facilitated the cleavage by the CXCR-4 DNA-enzyme. Furthermore, the di-DNA-enzyme was able to cleave the substrate RNA to completion. These DNA-enzymes, when introduced into a mammalian cell line expressing the appropriate chemokine receptor, interfered specifically with the HIV-1 coreceptor functions. Using this strategy, it may be possible to interfere with the infection and spread of R5 as well as X4 viruses. (C) 2000 Elsevier Science B.V.",
keywords = "Catalytic DNA, CCR5, Chemokine receptors, CXCR-4, DNA-enzymes, HIV-1 coreceptors",
author = "Shrabani Basu and Bandi Sriram and Ritu Goila and Banerjea, {Akhil C.}",
year = "2000",
month = "5",
doi = "10.1016/S0166-3542(00)00075-9",
language = "English (US)",
volume = "46",
pages = "125--134",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme

T2 - Inhibition of coreceptor function

AU - Basu, Shrabani

AU - Sriram, Bandi

AU - Goila, Ritu

AU - Banerjea, Akhil C.

PY - 2000/5

Y1 - 2000/5

N2 - HIV needs the chemokine receptors (HIV-1 coreceptors) to initiate infection and gain entry into a susceptible cell. CCR5 receptor is used by macrophage tropic viruses to establish infection, and CXCR-4 is used by T lymphocyte tropic virus which are usually found at the terminal stages of the disease. These chemokine receptors are, therefore, attractive targets to interfere with the entry as well as spread of HIV-1 in the host. As our antiviral approach, we have earlier assembled a DNA-enzyme-916 against CCR5 (Goila and Banerjea, 1998). We have now designed against the CXCR-4 gene a mono-DNA-enzyme, which showed sequence specific cleavage activity. When CXCR- 4-DNA-enzyme was placed in tandem with CCR5-DNA-enzyme, specific cleavage of their respective target sites were observed using a 60 bases long synthetic target RNA which possessed the target sites for both the DNA-enzymes. The cleavage by the CXCR-4 DNA-enzyme was found to be significantly more efficient than by the CCR5-DNA-enzyme. Analyses of the cleaved fragments by mono- and di-DNA-enzyme indicated strongly that hybridization of the CCR5- DNA-enzyme with its cognate target RNA, actually facilitated the cleavage by the CXCR-4 DNA-enzyme. Furthermore, the di-DNA-enzyme was able to cleave the substrate RNA to completion. These DNA-enzymes, when introduced into a mammalian cell line expressing the appropriate chemokine receptor, interfered specifically with the HIV-1 coreceptor functions. Using this strategy, it may be possible to interfere with the infection and spread of R5 as well as X4 viruses. (C) 2000 Elsevier Science B.V.

AB - HIV needs the chemokine receptors (HIV-1 coreceptors) to initiate infection and gain entry into a susceptible cell. CCR5 receptor is used by macrophage tropic viruses to establish infection, and CXCR-4 is used by T lymphocyte tropic virus which are usually found at the terminal stages of the disease. These chemokine receptors are, therefore, attractive targets to interfere with the entry as well as spread of HIV-1 in the host. As our antiviral approach, we have earlier assembled a DNA-enzyme-916 against CCR5 (Goila and Banerjea, 1998). We have now designed against the CXCR-4 gene a mono-DNA-enzyme, which showed sequence specific cleavage activity. When CXCR- 4-DNA-enzyme was placed in tandem with CCR5-DNA-enzyme, specific cleavage of their respective target sites were observed using a 60 bases long synthetic target RNA which possessed the target sites for both the DNA-enzymes. The cleavage by the CXCR-4 DNA-enzyme was found to be significantly more efficient than by the CCR5-DNA-enzyme. Analyses of the cleaved fragments by mono- and di-DNA-enzyme indicated strongly that hybridization of the CCR5- DNA-enzyme with its cognate target RNA, actually facilitated the cleavage by the CXCR-4 DNA-enzyme. Furthermore, the di-DNA-enzyme was able to cleave the substrate RNA to completion. These DNA-enzymes, when introduced into a mammalian cell line expressing the appropriate chemokine receptor, interfered specifically with the HIV-1 coreceptor functions. Using this strategy, it may be possible to interfere with the infection and spread of R5 as well as X4 viruses. (C) 2000 Elsevier Science B.V.

KW - Catalytic DNA

KW - CCR5

KW - Chemokine receptors

KW - CXCR-4

KW - DNA-enzymes

KW - HIV-1 coreceptors

UR - http://www.scopus.com/inward/record.url?scp=0034036143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034036143&partnerID=8YFLogxK

U2 - 10.1016/S0166-3542(00)00075-9

DO - 10.1016/S0166-3542(00)00075-9

M3 - Article

C2 - 10854664

AN - SCOPUS:0034036143

VL - 46

SP - 125

EP - 134

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 2

ER -